Previous issues
-
Previous issues
Volume 28(4) Oct 2022
Print ISSN: 2287-2728
Online ISSN: 2287-285X
- Guideline 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
- Clin Mol Hepatol. 2022;28(4):583-705.
- Reviews The emerging roles of extracellular vesicles as intercellular messengers in liver physiology and pathology
- Youngseok Lee, Jong-Hoon Kim
- Clin Mol Hepatol. 2022;28(4):706-724.
- Old and new classes of glucose-lowering agents as treatments for non-alcoholic fatty liver disease: A narrative review
- Lei Miao, Jing Xu, Giovanni Targher, Christopher D Byrne, Ming-Hua Zheng
- Clin Mol Hepatol. 2022;28(4):725-738.
- Prediction models of hepatocellular carcinoma recurrence after liver transplantation: A comprehensive review
- Sang Jin Kim, Jong Man Kim
- Clin Mol Hepatol. 2022;28(4):739-753.
- Deep learning-based prediction of molecular cancer biomarkers from tissue slides: A new tool for precision oncology
- Sung Hak Lee, Hyun-Jong Jang
- Clin Mol Hepatol. 2022;28(4):754-772.
- Impact of diabetes, obesity, and dyslipidemia on the risk of hepatocellular carcinoma in patients with chronic liver diseases
- Hwang Sik Shin, Baek Gyu Jun, Sang-Wook Yi
- Clin Mol Hepatol. 2022;28(4):773-789.
- Nonalcoholic fatty liver disease versus metabolic-associated fatty liver disease: Prevalence, outcomes and implications of a change in name
- Cheng Han Ng, Daniel Q. Huang, Mindie H. Nguyen
- Clin Mol Hepatol. 2022;28(4):790-801.
- Editorials Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations
- Soon Sun Kim, Jae Youn Cheong
- Clin Mol Hepatol. 2022;28(4):802-805.
- Repurposing drugs to target nonalcoholic steatohepatitis: Auranofin, a gold-organic molecule complex for the treatment of a specifc complex trait
- Carlos J. Pirola, Silvia Sookoian
- Clin Mol Hepatol. 2022;28(4):806-809.
- Surveillance for hepatocellular carcinoma: It is time to move forward
- Bo Hyun Kim, Yuri Cho, Joong-Won Park
- Clin Mol Hepatol. 2022;28(4):810-813.
- Original Articles The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults
- Jun-Hyuk Lee, Kyongmin Park, Hye Sun Lee, Hoon-Ki Park, Jee Hye Han, Sang Bong Ahn
- Clin Mol Hepatol. 2022;28(4):814-826.
- Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF- κB signaling pathways
- Seung Min Lee, Dong Hee Koh, Dae Won Jun, Yoon Jin Roh, Hyeon Tae Kang, Ju Hee Oh, Hyun Sung Kim
- Clin Mol Hepatol. 2022;28(4):827-840.
- Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
- Michael H. Le, Yee Hui Yeo, Biyao Zou, Scott Barnet, Linda Henry, Ramsey Cheung, Mindie H. Nguyen
- Clin Mol Hepatol. 2022;28(4):841-850.
- Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease
- Won Sohn, Danbee Kang, Minwoong Kang, Eliseo Guallar, Juhee Cho, Yong-Han Paik
- Clin Mol Hepatol. 2022;28(4):851-863.
- Global prevalence of depression and anxiety in patients with hepatocellular carcinoma: Systematic review and meta-analysis
- Darren Jun Hao Tan, Sabrina Xin Zi Quek, Jie Ning Yong, Adithya Suresh, Kaiser Xuan Ming Koh, Wen Hui Lim, Jingxuan Quek, Ansel Tang, Caitlyn Tan, Benjamin Nah, Eunice Tan, Taisei Keitoku, Mark D. Muthiah, Nicholas Syn, Cheng Han Ng, Beom Kyung Kim, Nobuharu Tamaki, Cyrus Su Hui Ho, Rohit Loomba, Daniel Q. Huang
- Clin Mol Hepatol. 2022;28(4):864-875.
- Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis
- Tae Hyung Kim, Young Kul Jung, Hyung Joon Yim, Joo Won Baik, Sun Young Yim, Young-Sun Lee, Yeon Seok Seo, Ji Hoon Kim, Jong Eun Yeon, Kwan Soo Byun
- Clin Mol Hepatol. 2022;28(4):876-889.
- COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis
- Ka Shing Cheung, Chiu Hang Mok, Xianhua Mao, Ruiqi Zhang, Ivan FN Hung, Wai Kay Seto, Man Fung Yuen
- Clin Mol Hepatol. 2022;28(4):890-911.
- Decreased vitamin D-binding protein level portends poor outcome in acute-on-chronic liver failure caused by hepatitis B virus
- Daxian Wu, Qunfang Rao, Zhongyang Xie, Xiaoqing Zhu, Yuanmei Che, Jian Wu, Hainv Gao, Jingyu Zhang, Zhouhua Hou, Xiaoyu Cheng, Zeyu Sun
- Clin Mol Hepatol. 2022;28(4):912-925.
- Letters to the Editor Autoimmune liver disease represented as primary biliary cholangitis after SARS-CoV-2 infection: A need for population-based cohort study
- Soon Kyu Lee, Jung Hyun Kwon, Nara Yoon, Soon Woo Nam, Pil Soo Sung
- Clin Mol Hepatol. 2022;28(4):926-928.
- Forms of cholangitis to be considered after SARS-CoV-2 infection
- Ju-Yeon Cho, Young-Sun Lee, Soon Sun Kim, Do Seon Song, Jeong-Hoon Lee, Ji Hoon Kim
- Clin Mol Hepatol. 2022;28(4):929-930.
- Non-alcoholic fatty liver disease and the risk of dementia: A meta-analysis of cohort studies
- Li-Yu Lu, Min-You Wu, Yung-Shuo Kao, Cheng-Hsien Hung
- Clin Mol Hepatol. 2022;28(4):931-932.
- Non-alcoholic fatty liver disease and risk of dementia: Unmet need for a pooled analysis of cohort studies
- Seogsong Jeong, Won Kim, Sang Min Park
- Clin Mol Hepatol. 2022;28(4):933-934.
- Snapshot Personalized medicine in nonalcoholic fatty liver disease
- Carlos J. Pirola, Silvia Sookoian
- Clin Mol Hepatol. 2022;28(4):935-938.
- Erratums Erratum to ‘History and future of hepatitis B virus control in South Korea’ [Clin Mol Hepatol 2021;27:620-622]
- Do Young Kim
- Clin Mol Hepatol. 2022;28(4):939-939.
- Erratum to ‘KASL clinical practice guidelines for management of chronic hepatitis B’ [Clin Mol Hepatol 2022;28:276-331]
- Clin Mol Hepatol. 2022;28(4):940-940.